Yg. Kwak et al., KR-30450, A NEWLY SYNTHESIZED BENZOPYRAN DERIVATIVE, ACTIVATES THE CARDIAC ATP-SENSITIVE K+ CHANNEL, The Journal of pharmacology and experimental therapeutics, 275(2), 1995, pp. 807-812
KR-30450 (2-(2 ''(1 '',3 (2'-oxo-1'-pyrrollidinyl)-6-nitro-2H-1-benzop
yren) is a newly synthesized benzopyran derivative. We examined the ef
fect of KR-30450 on the action potential duration of isolated rat papi
llary muscle and on the ATP-sensitive K+ channel (K-ATP activity in si
ngle rat ventricular myocytes with 3 M KCl-filled conventional microel
ectrode and patch clamp techniques. KR-30450 (10(-7) similar to 10(-5)
M) reduced the action potential duration in a concentration-dependent
manner and this was inhibited by 3 mu M glibenclamide, suggesting tha
t K-ATP was involved. In cell-attached patches, KR-30450 (10(-5) M) in
the pipette activated the K-ATP which was closed by 3 mu M glibenclam
ide. In inside-out patches, the effects of KR-30450 on K-ATP activity
were examined before and after run-down of the channel. Before run-dow
n, KR-30450 increased the K-ATP activity only in the presence of ATP a
nd shifted the [ATP](i) - K-ATP activity relationship to the right. Af
ter run-down, KR-30450 did not affect the K-ATP activity either in the
presence or absence of 3 mM UDP, but increased the UDP-induced K-ATP
activity in the presence of 1 mM ATP-gamma-S. From these results, we c
onclude that KR-30450 antagonizes the inhibitory effect of ATP on the
K-ATP in a competitive manner. These effects of KR-30450 are similar t
o those of ER-001533 and HOE-234, but different from those of pinacidi
l and lemakalim.